Your browser doesn't support javascript.
loading
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Erickson, Craig A; Veenstra-Vanderweele, Jeremy M; Melmed, Raun D; McCracken, James T; Ginsberg, Lawrence D; Sikich, Linmarie; Scahill, Lawrence; Cherubini, Maryann; Zarevics, Peter; Walton-Bowen, Karen; Carpenter, Randall L; Bear, Mark F; Wang, Paul P; King, Bryan H.
Affiliation
  • Erickson CA; Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
J Autism Dev Disord ; 44(4): 958-64, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24272415
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Baclofen / Child Development Disorders, Pervasive / GABA-B Receptor Agonists Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Autism Dev Disord Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Baclofen / Child Development Disorders, Pervasive / GABA-B Receptor Agonists Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Autism Dev Disord Year: 2014 Document type: Article